mij821
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Feb 8, 2019 (NCT03756129)
Timeline
Indications
Mechanism of action
GRIN2A antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05666687 | Phase 1 | Jan 11, 2023 | Novartis, Parexel |
| NCT05454410 | Phase 2 | Jan 4, 2023 | Novartis |
| NCT04722666 | Phase 2 | Jul 20, 2021 | Novartis |
| NCT03756129 | Phase 2 | Feb 8, 2019 | Novartis |
Showing 4 of 4 trials
Page 1 / 1